PHARMACY

NBA Cares takes vaccination awareness program to Detroit

BY Allison Cerra

DETROIT The charitable arm of the NBA is expanding its education program about adolescent vaccinations to Detroit.

Detroit Pistons forward Jonas Jerebko and NBA Legend Bob Lanier teamed up with NBA Cares and the Society for Adolescent Medicine to bring Vaccines for Teens to the Metro Detroit community. Vaccines for Teens is a national multimedia campaign designed to educate teens and their parents about the importance of vaccination against serious and potentially life-threatening diseases.

To tip off the campaign locally, Jerebko and Lanier appeared at the Arts and Technology Academy in Pontiac, Mich., to urge parents of preteens and teens to discuss adolescent vaccinations with their family physicians.

Teens are at risk for influenza disease, both seasonal and the influenza A (H1N1) virus, as well as for other serious infectious diseases such as meningococcal disease (including meningitis) and whooping cough (pertussis). The basketball superstar and local community leaders agree it is more important than ever to help protect preteens and teens in the Metro Detroit area from the potentially life-threatening complications of these diseases.

“Vaccination can help teens grow into healthy adults, and is beneficial for the students at Arts and Technology Academy of Pontiac and for teens throughout the Metro Detroit area,” said Jerebko. “In basketball, the best offense is a good defense, and the same holds true for protecting teen health.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

FDA committee to review Qnexa

BY Alaric DeArment

MOUNTAIN VIEW, Calif. A Food and Drug Administration committee will review a drug by Vivus for obesity, the drug maker announced Friday.

The company said the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee was tentatively scheduled to review its application for Qnexa (phentermine and topiramate) on July 15. Vivus submitted its approval application for the drug in late December and expects the FDA to complete its review in October.

“Review by the advisory committee represents a critical milestone for Qnexa and for Vivus,” Vivus CEO Leland Wilson said in a statement. “We believe Qnexa, if approved, could become a treatment option for obese patients.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Op-ed on healthcare reform calls for expanded role of nurse practitioners in Texas

BY Allison Cerra

SAN ANTONIO An opinion piece written for the San Antonio Express-News urges health reform in Texas and the need for nurse practitioners to be "given the right to diagnose and prescribe on their own," as done in retail clinics.

 

"Texas has only a few retail clinics; San Antonio doesn’t have any. The problem is cost," David Hendricks wrote Tuesday. "In Texas, state law requires doctors to be on site for 20% of operating hours in urban areas. In rural and designated medically underserved areas, a doctor must review 10% of a clinic’s charts every 10 days. The cost of physician oversight is too high for [the Walgreens and CVS chains], along with the retail clinic companies, to roll out full market coverage in Texas."

 

Hendricks does, however, point out retail clinics’ cost-effectiveness, citing the acceptance of health insurance plans, with fees capped at less than $100.

 

"Healthcare reform won’t mean as much as it could in Texas until this change (expanding the role of nurse practitioners and clinical nurse specialists) happens," Hendricks concluded.

 

 

To view Hendricks’ piece, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES